Back to news archive
News 2019-04-03

Closes fully subscribed USD 4.6 million rights issue

Gradientech today announced it has closed a fully subscribed rights issue totalling USD 4.6 million (SEK 42.5 million). Existing owners, as well as new parties appointed by Erik Penser Bank AB, who acted as financial advisor, have subscribed. Bird & Bird Lawyers acted as legal advisors.

Link to press-release

Gradientech is an ISO13485 certified company since 2017

Contact

Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala
Sweden

sales@gradientech.se

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book